Vertex spikes - Analysis - 05-06-2023

Vertex Pharmaceuticals Incorporated's stock (VRTX) surged in the intraday levels, managing to shake off negative pressure from the 50-day SMA, coupled with positive signals from the RSI after reaching oversold levels, amid the dominance of the main upward trend in the medium and short terms, marking a strong profit of 3.14% in the last session, or 10.16 points, and settling at 333.78.

Therefore we expect more gains for the stock, targeting the resistance of 354.46, provided the support of 323.61 holds on.

Expected trend for today: Bullish